BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29336893)

  • 1. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection.
    Mowbray NG; Griffith D; Hammoda M; Shingler G; Kambal A; Al-Sarireh B
    HPB (Oxford); 2018 May; 20(5):379-384. PubMed ID: 29336893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.
    Chawla A; Huang TL; Ibrahim AM; Hardacre JM; Siegel C; Ammori JB
    HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review.
    Stevens L; Pathak S; Nunes QM; Pandanaboyana S; Macutkiewicz C; Smart N; Smith AM
    HPB (Oxford); 2015 Apr; 17(4):285-91. PubMed ID: 25431369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
    World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in total lymphocyte count and neutrophil-to-lymphocyte ratio after curative pancreatectomy in patients with pancreas adenocarcinoma and their prognostic role.
    Kim EY; Hong TH
    J Surg Oncol; 2019 Dec; 120(7):1102-1111. PubMed ID: 31598983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
    Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
    Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
    Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas.
    Yang F; Bao Y; Zhou Z; Jin C; Fu D
    J Surg Oncol; 2019 Aug; 120(2):241-248. PubMed ID: 31041808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combination of Neutrophil-to-lymphocyte Ratio and Serum Carbohydrate Antigen 19-9 Level as a Prognostic Indicator in Patients with Recurrent Pancreatic Cancer.
    Sakamoto T; Saito H; Uchinaka EI; Morimoto M; Amisaki M; Tokuyasu N; Honjo S; Ashida K; Fujiwara Y
    Anticancer Res; 2018 Sep; 38(9):5497-5503. PubMed ID: 30194208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.
    Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C
    Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Cheng H; Long F; Jaiswar M; Yang L; Wang C; Zhou Z
    Sci Rep; 2015 Jul; 5():11026. PubMed ID: 26226887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients.
    Zhou Y; Wei Q; Fan J; Cheng S; Ding W; Hua Z
    Clin Chim Acta; 2018 Apr; 479():181-189. PubMed ID: 29407690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
    Tsujita E; Ikeda Y; Kinjo N; Yamashita YI; Hisano T; Furukawa M; Taguchi KI; Morita M; Toh Y; Okamura T
    Am Surg; 2017 Jun; 83(6):610-616. PubMed ID: 28637563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
    Guo J; Wu M; Guo L; Zuo Q
    Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
    Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
    Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.